Keywords: mevacor, study, may, extend, lipid-lowering, therapy, merck

Mevacor Study May Extend Lipid-Lowering Therapy

Article | 13 November 1997

Print This

Merck & Co's HMG-CoA reductase inhibitor Mevacor (lovastatin) - theoldest of the statin drugs on the market - has become the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in